DYN FY 2025 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DYNDyne Therapeutics, Inc.

$3B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$468M

Net Income

-$446M

EPS (Diluted)

$-3.47

Cash Flow

Operating Cash Flow

-$403M

Free Cash Flow

-$405M

Stock-Based Comp.

$46M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$215M

Stockholders' Equity

$972M

Cash & Equivalents

$893M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$2M	+100.0%
Operating Income	-$468M	-$344M	-36.1%
Net Income	-$446M	-$317M	-40.6%